MRSA: Legal Implications

According to the National Institute of Allergy and Infectious Diseases, a 2005 study comparing patients without S. aureus and those infected with it showed that those with the infection had nearly 3 times the length in inpatient stay, 3 times the cost of their hospitalization and 5 times the risk of an in-hospital death. (National [&hellip Read More...

MRSA: Prevention & Treatment

The Centers for Disease Control and Prevention estimate that “2 in 100 people carry MRSA”. (Centers for Disease Control and Prevention, 2014) Hospitalized patients are usually tested prior to surgical or other invasive procedures. The screening process is painless. A cotton swab is swiped across the area that’s to be tested such as the skin, [&hellip Read More...

MRSA: High Risk Populations

There are people who are at higher risks of developing complications to these infections. Patients with weakened immune systems who are unable to fight off the infection include those with cancer and receiving chemotherapy; those with autoimmune illnesses such as rheumatoid arthritis, transplant recipients, intravenous drug users and patients with kidney diseases requiring dialysis. A [&hellip Read More...

MRSA: Transmission

Staphylococcus aureus, or S. aureus, has been around for more than 100 years. Over the years the increasing overuse and misuse of antibiotics to treat bacteria, including, S. aureus, has caused bacteria to become resistant to many common antibiotics used to treat infections. This is a tremendous concern in hospitals, medical centers and nursing homes–typical [&hellip Read More...